Invitation to attend Global Health Partner’s conference call in English regarding presentation of the Interim report January-September 2013. Time: Wednesday 30 October 2013 at 9.30 a.m. CET Please dial in ten minutes prior to the conference to participate on the following phone number: +46 (0)8 505 564 81 Global Health Partner participants: Marianne Dicander Alexandersson, CEO Tobias Linebäck, CFO The press release for Global Health Partner’s Interim report January-September 2013 will be released on Wednesday 30 October 2013 at 8 a.m. CET. Before the conference call, slides will be available at the company web page, www.globalhealthpartner.com. The conference call will also be recorded and available at www.globalhealthpartner.com. 23 October 2013 Gothenburg, Sweden Global Health Partner AB (publ) Queries should be addressed to: Tobias Linebäck, CFO and Head of Investor Relations, phone: +46-708 55 37 19 Global Health Partner is an internationally active healthcare provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the healthcare industry, where leading doctors become partners and shareholders. Multiple clinics with high patient volumes within the same diagnostic area produce increased efficiency and higher quality, which is the cornerstone of Global Health Partner's business philosophy – “Quality through Specialisation”. Global Health Partner’s shares are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation “GHP”. Global Health Partner AB (publ) | www.globalhealthpartner.com Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden Tel +46-31 712 53 00 | Fax +46-31 313 13 21 This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
Conference call on Interim report January-September 2013
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Kohl's Earnings Expectations: What Investors Need to Know
Kohl's Earnings Preview: Investor Insights Kohl's (NYSE: KSS) is set to reveal its quarterly earnings report soon. Anticipations among investors are high as they await crucial details that might affect stock movements. Analysts are projecting an earnings per share (EPS) of $0.31, which could indicate trends worth examining for future investment strategies. Importance of...
Continue Reading
Challenges Facing US Crypto Reserve Expansion Beyond Bitcoin
Concerns Over U.S. Crypto Reserve Expansion Analysts have raised significant concerns regarding the proposed U.S. Crypto Strategic Reserve and its expansion beyond Bitcoin. With financial backing potentially coming from Federal Reserve or Treasury funds, experts argue that significant hurdles remain. Market Response to Presidential Announcement The announcement of the...
Continue Reading
Financial Instability: A Key Barrier to America’s Health
Understanding Financial Instability's Impact on Health The National Financial Educators Council (NFEC) recently raised an alarm regarding the Make America Healthy Again (MAHA) movement, emphasizing that without addressing financial instability, this initiative may fall short of its goals. The NFEC is advocating for a nationwide acknowledgment of financial instability as a...
Continue Reading
U.S. Labor Market Strong Despite Economic Challenges Ahead
U.S. Labor Market Shows Resilience Amid Economic Changes Recently released job figures have painted a picture of a robust U.S. labor market. Despite some signs of slowing down, the overall state remains encouraging, with unemployment stabilizing around 4.1%. This is consistent with what is generally perceived as full employment levels. Raphael Bostic, the President of the...
Continue Reading
Intelligent Bio Solutions Set for Key Conference Participation
Intelligent Bio Solutions Inc. at the Upcoming Micro-Cap Conference Intelligent Bio Solutions Inc. (NASDAQ: INBS) is excited to announce its participation in an important micro-cap virtual conference. This event provides a significant platform for the company's management team to engage with investors and showcase their cutting-edge technologies. Put aside any...
Continue Reading